Skip to main content
. 2020 Nov 11;2020:9740938. doi: 10.1155/2020/9740938

Table 3.

Procedural and in-hospital outcome (n = 104 patients).

SCB (n = 43) RA (n = 61) p value
Procedural duration (min) 77.9 ± 46.3 96.5 ± 36.3 0.02
Fluoroscopy time (min) 19.4 ± 15.2 26.9 ± 12.5 0.01
Contrast amount (ml) 234.3 ± 107.1 273.0 ± 116.1 0.08
Large dissection (>5 mm) 6 (13%) 1 (2%) 0.02
Perforation 2 (5%) 2 (3%) 1.00
Pericardial effusion 0 (0%) 2 (3%) 0.51
No/slow flow 0 (0%) 2 (2%) 0.49
Final TIMI flow < III in MB 0 (0%) 1 (2%) 0.41
Residual stenosis > 20% in MB 2 (5%) 0 (0%) 0.17
Stent failure 0 (0%) 4 (7%) 0.14
Crossover from SCB to RA∗∗ 0 (0%) 11 (18%) 0.002
Death 0 (0%) 0 (0%) 1.00
Myocardial infarction 0 (0%) 1 (2%) 1.00
Target vessel re-PCI 0 (0%) 0 (0%) 1.00
CABG 0 (0%) 0 (0%) 1.00
Stent thrombosis 0 (0%) 0 (0%) 1.00
Access site complications 2 (5%) 2 (3%) 1.00

Values are n (%) or mean ± SD; CABG = coronary artery bypass graft; MB = main branch; PCI = percutaneous coronary intervention; RA = rotational atherectomy; SCB = scoring/cutting balloon; TIMI = thrombolysis in myocardial infarction. Stent failure occurred in patients initially randomized to an SCB strategy, and a crossover to RA was performed. ∗∗The interpretation of this finding is biased by the fact that crossover patients who were initially randomized to an SCB strategy are included in the RA group.